Re: PDDI Min Info Model Task Force - Please review penultimate Community Group Note by 5/17/18

Rich,

I didn't finish the document yet, but there were two issues that I
previously raised that were not addressed:

I do not think Seriousness and Severity are semantically different to
readers. I would rather you use "Morbidity" and "Reaction Intensity" for
these terms. At least I can sorta tell these apart.

I would rather the sample XML use tags that do not include colons and are
semantically meaningful. <interaction></interaction> rather than
<MPIO:1111000>, which is meaningless to me.


--Sam


On Thu, Apr 26, 2018 at 11:15 AM, Richard Boyce <rdb20@pitt.edu> wrote:

> Dear Task Force Colleagues,
>
> I am pleased to announce that we have completed major revision on the
> draft community group note  on the topic of a potential drug-drug
> interaction (PDDI) minimum information model. The content of the note is
> not very different from prior versions but the organization and format is
> considerably changed with the goal of making it a much more usable report
> for a technical audience.
>
> I have checked with the other editors on this note and have received very
> positive feedback. I am asking all contributors for any final feedback
> before we officially publish as W3C Community Group Note.
>
> You can view the note here:
>
> - Temporary web location (what the note will ultimately look like):
> https://dbmi-icode-01.dbmi.pitt.edu/dikb-evidence/hcls-drug-
> drug-interaction/index.html
>
> - Word and PDF versions in case you want to make edits/comments (please
> note that the final version of this will be rendered as shown on the web
> version)
>
> Please reply directly to me or on the Community Group mailing list (
> public-hclscg@w3.org) with any comments, edits, or concerns within three
> weeks (by May 17th). Please ensure that your name and affiliation is
> written correctly. Also, an funding acknowledgement that needs mentioned.
>
> thanks a bunch!
>
> -Rich
>
> --
> Richard D Boyce, PhD
> Associate Professor of Biomedical Informatics and Clinical and
> Translational Science in the Clinical and Translational
> Science Institute
> Director of the Informatics Core for the Center of Excellence for Natural
> Product- Drug Interaction Research (NaPDI)
> Faculty, Center for Pharmaceutical Policy and Prescribing
> Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research
> and Training Program
> University of Pittsburgh
> rdb20@pitt.edu
> Office: 412-648-9219
> Twitter: @bhaapgh
>
>